Global EditionASIA 中文雙語(yǔ)Fran?ais
China
Home / China / Health

China approves 48 innovative drugs in 2024

By Wang Xiaoyu | chinadaily.com.cn | Updated: 2025-03-18 20:36
Share
Share - WeChat

China approved 48 first-in-class innovative drugs in 2024, covering nearly 20 therapeutic areas, including oncology, neurological disorders, endocrine diseases and anti-infective medicines, according to a report released by the National Medical Products Administration on Tuesday.

The report stated that 17 among the 48 novel drugs received market approval through a priority review pathway, 11 gained conditional market approval and 13 were included in breakthrough therapy programs during clinical trials.

In addition, the nation also approved 55 rare disease medicines and 106 pediatric medicines. Furthermore, 35 medications were granted expanded pediatric indications, which is expected to help alleviate the shortage of pediatric medication options, said the report.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
精品无码久久久久久尤物,99视频这有这里有精品,国产UU精品无码视频,女同精品一区二区网站